Lars Jørgen Østergaard

Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Documents

DOI

  • Bo Langhoff Hønge
  • Sanne Jespersen
  • Candida Medina, National HIV Programme, Ministry of Health, Bissau, Guinea-Bissau.
  • ,
  • David da Silva Té, National HIV Programme, Ministry of Health, Bissau, Guinea-Bissau.
  • ,
  • Zacarias José da Silva, Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau; National Public Health Laboratory, Bissau, Guinea-Bissau.
  • ,
  • Sharon R Lewin, Department of Infectious Diseases, Alfred Hospital and Monash University, Australia; Centre for Biomedical Research, Burnet Institute, Melbourne, Australia.
  • ,
  • Lars Ostergaard
  • Alex Lund Laursen
  • Henrik Krarup
  • Christian Erikstrup
  • Christian Wejse
  • Bissau HIV Cohort Study Group

OBJECTIVES: To estimate the prevalence and determine the clinical presentation of risk factors of hepatitis C virus (HCV) among HIV-infected patients in Bissau, Guinea-Bissau.

METHODS: In this cross-sectional study, we included individuals who had a routine blood analysis performed during the period April 28 to September 30, 2011. Patient samples were tested for HCV antibodies (anti-HCV) with a chemiluminescence test (Architect, Abbott, USA) and INNO-LIA HCV Score (Innogenetics, Belgium). HCV viral load and genotype were analyzed using an in-house real-time PCR method.

RESULTS: In total, 576 patients were included (417 HIV-1, 104 HIV-2, and 55 HIV-1/2). Ten (1.7%) patients were anti-HCV-positive and eight (1.4%) patients had detectable HCV RNA; all were genotype 2. In a multivariable logistic regression analysis, age >50 years was associated with anti-HCV reactivity (p<0.01). No subjective symptoms or objective signs were more prevalent among patients with detectable HCV RNA compared to patients without detectable HCV RNA. Biochemically, detectable HCV RNA was associated with elevated amylase (83.3% vs. 38.6%, p=0.03), but not with the liver enzymes alanine aminotransferase and aspartate aminotransferase.

CONCLUSIONS: The prevalence of anti-HCV was low and comparable to similar settings, and genotype analysis confirmed the presence of genotype 2 in West Africa.

Translated title of the contributionHepatitis C forekomst blandt HIV smittede i Guinea Bissau
Original languageEnglish
JournalInternational Journal of Infectious Diseases
Volume28C
Pages (from-to)35-40
Number of pages6
ISSN1201-9712
DOIs
Publication statusPublished - 16 Sep 2014

See relations at Aarhus University Citationformats

Download statistics

No data available

ID: 82191678